Ju Fu Tang Biotech Holdings Co (HKSE:08217) Total Receivables: HK$26.87 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08217 Ju Fu Tang Biotech Holdings Co Ltd HKSE:08217
36 GF Score
Price HK$0.11
GF Value HK$0.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ju Fu Tang Biotech Holdings Co Total Receivables?

Ju Fu Tang Biotech Holdings Co HKSE:08217 -3.60% 36 Total Receivables is HK$26.87 Mil as of Mar. 2026. GuruFocus rates HKSE:08217 with a GF Score™ of 36/100 and a GF Value™ of HK$0.15 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Ju Fu Tang Biotech Holdings Co's Total Receivables for the quarter that ended in Mar. 2026 was HK$26.87 Mil.

Ju Fu Tang Biotech Holdings Co Total Receivables Related Terms

Ju Fu Tang Biotech Holdings Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Ju Fu Tang Biotech Holdings Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ju Fu Tang Biotech Holdings Co Total Receivables Chart

Ju Fu Tang Biotech Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.41 56.28 49.56 40.59 26.87

Ju Fu Tang Biotech Holdings Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.56 49.29 40.59 35.25 26.87
HKSE:08217
36GF Score
Ju Fu Tang Biotech Holdings Co Ltd HKSE:08217
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ju Fu Tang Biotech Holdings Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of HK$26.87 Mil mean?
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a Total Receivables of HK$26.87 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors.
Is Ju Fu Tang Biotech Holdings Co's Total Receivables too high?
Ju Fu Tang Biotech Holdings Co's current Total Receivables is HK$26.87 Mil. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's Total Receivables compare to PWR and FIX?
Ju Fu Tang Biotech Holdings Co's Total Receivables of HK$26.87 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Construction company?
A good Total Receivables depends on the Construction industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. Ju Fu Tang Biotech Holdings Co's current Total Receivables is HK$26.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 28.7% below its estimated fair value. The current Total Receivables is HK$26.87 Mil. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current Total Receivables is HK$26.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?

Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued. The current stock price of HK$0.11 is trading 28.7% below its estimated GF Value™ of HK$0.15. GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.

Key valuation signals for HKSE:08217:

  • Total Receivables: HK$26.87 Mil
  • GF Value™: HK$0.15 vs. price of HK$0.11 (28.7% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ju Fu Tang Biotech Holdings Co Business Description

Address 489 Hennessy Road, Unit 2202, 22nd Floor, Causeway Bay Plaza I, Causeway Bay, Hong Kong, HKG
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score

Get the complete analysis for HKSE:08217

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.11
Price
HK$0.15
GF Value